Cargando…

Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow

Mesenchymal stromal cells (MSCs) have been the object of extensive research for decades, due to their intrinsic clinical value. Nonetheless, the unambiguous identification of a unique in vivo MSC progenitor is still lacking, and the hypothesis that these multipotent cells could possibly arise from d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacini, Simone, Barachini, Serena, Montali, Marina, Carnicelli, Vittoria, Fazzi, Rita, Parchi, Paolo, Petrini, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2016
Materias:	Original Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854213/ https://www.ncbi.nlm.nih.gov/pubmed/26975798 http://dx.doi.org/10.1089/scd.2015.0344

Ejemplares similares

Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow
por: Montali, Marina, et al.
Publicado: (2016)

Human adult mesangiogenic progenitor cells reveal an early angiogenic potential, which is lost after mesengenic differentiation
por: Montali, Marina, et al.
Publicado: (2017)

Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma
por: Pacini, Simone, et al.
Publicado: (2019)

Nanotopography Induced Human Bone Marrow Mesangiogenic Progenitor Cells (MPCs) to Mesenchymal Stromal Cells (MSCs) Transition
por: Antonini, Sara, et al.
Publicado: (2016)

Mesangiogenic Progenitor Cells Are Tissue Specific and Cannot Be Isolated From Adipose Tissue or Umbilical Cord Blood
por: Barachini, Serena, et al.
Publicado: (2021)

Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
por: Tripaldi, Romina, et al.
Publicado: (2021)

Mesodermal Progenitor Cells (MPCs) Differentiate into Mesenchymal Stromal Cells (MSCs) by Activation of Wnt5/Calmodulin Signalling Pathway
por: Fazzi, Rita, et al.
Publicado: (2011)

High NESTIN Expression Marks the Endosteal Capillary Network in Human Bone Marrow
por: Panvini, Francesca M., et al.
Publicado: (2020)

Constitutive Expression of Pluripotency-Associated Genes in Mesodermal Progenitor Cells (MPCs)
por: Pacini, Simone, et al.
Publicado: (2010)

CD32 is enriched on CD4(dim)CD8(bright) T cells
por: Virdi, Amber K., et al.
Publicado: (2020)

Emergence of AnnexinV(pos) CD31(neg) CD42b(low/neg) extracellular vesicles in plasma of humans at extreme altitude
por: Utermöhlen, Olaf, et al.
Publicado: (2019)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

CD25(bright)CD4(+ )regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease
por: Cao, Duojia, et al.
Publicado: (2004)

The Role of CD4(+)CD25(bright) Regulatory T Cells in the Maintenance of Pregnancy, Premature Rupture of Membranes, and Labor
por: Seol, Hyun-Joo, et al.
Publicado: (2008)

CD25brightCD4(+ )regulatory T cells accumulate in inflamed joints of patients with chronic rheumatic disease
por: Cao, D, et al.
Publicado: (2004)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
por: Fraccarollo, Daniela, et al.
Publicado: (2021)

CD3(+)CD4(neg)CD8(neg) (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a(+) cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis
por: Ferraz, Raquel, et al.
Publicado: (2017)

Regulation of Development of CD56(bright)CD11c(+) NK-like Cells with Helper Function by IL-18
por: Li, Wen, et al.
Publicado: (2013)

Reduction of the CD16(−)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2013)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

Transcriptome analysis reveals similarities between human blood CD3(−) CD56(bright) cells and mouse CD127(+) innate lymphoid cells
por: Allan, David S. J., et al.
Publicado: (2017)

Ageing is associated with a decline in peripheral blood CD56(bright )NK cells
por: Chidrawar, Shivani M, et al.
Publicado: (2006)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

Circulating CD14(bright)CD16(+) ‘Intermediate’ Monocytes Exhibit Enhanced Parasite Pattern Recognition in Human Helminth Infection
por: Turner, Joseph D., et al.
Publicado: (2014)

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients
por: Guo, Chuang, et al.
Publicado: (2016)

CD14(bright)CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis
por: Tsukamoto, Masako, et al.
Publicado: (2017)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Dynamic regulation of CD24 and the invasive, CD44(pos)CD24(neg )phenotype in breast cancer cell lines
por: Meyer, Matthew J, et al.
Publicado: (2009)

The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients
por: Dietz, Allan B, et al.
Publicado: (2013)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
por: Veneziani, Irene, et al.
Publicado: (2022)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ahpki0i9e1l071t1l39j279put